Frankfurt - Delayed Quote EUR

CK Life Sciences Int'l., (Holdings) Inc. (LSI.F)

Compare
0.0355 0.0000 (0.00%)
At close: June 17 at 8:06 AM GMT+2
Loading Chart for LSI.F
DELL
  • Previous Close 0.0355
  • Open 0.0355
  • Bid 0.0355 x 5270000
  • Ask 0.0470 x 5270000
  • Day's Range 0.0355 - 0.0355
  • 52 Week Range 0.0315 - 0.0860
  • Volume 3,000
  • Avg. Volume 0
  • Market Cap (intraday) 406.798M
  • Beta (5Y Monthly) 0.15
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date Mar 19, 2024
  • Forward Dividend & Yield 0.00 (2.22%)
  • Ex-Dividend Date May 23, 2023
  • 1y Target Est --

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. The company was founded in 1999 and is headquartered in Tai Po, Hong Kong.

www.ck-lifesciences.com

1,932

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LSI.F

Performance Overview: LSI.F

Trailing total returns as of 6/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

LSI.F
46.21%
HANG SENG INDEX
5.02%

1-Year Return

LSI.F
56.71%
HANG SENG INDEX
10.67%

3-Year Return

LSI.F
50.39%
HANG SENG INDEX
37.31%

5-Year Return

LSI.F
31.40%
HANG SENG INDEX
34.25%

Compare To: LSI.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LSI.F

Valuation Measures

Annual
As of 6/14/2024
  • Market Cap

    406.80M

  • Enterprise Value

    1.03B

  • Trailing P/E

    165.42

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.54

  • Price/Book (mrq)

    0.68

  • Enterprise Value/Revenue

    1.63

  • Enterprise Value/EBITDA

    13.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.32%

  • Return on Assets (ttm)

    1.24%

  • Return on Equity (ttm)

    0.41%

  • Revenue (ttm)

    5.32B

  • Net Income Avi to Common (ttm)

    17.25M

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    676.16M

  • Total Debt/Equity (mrq)

    141.58%

  • Levered Free Cash Flow (ttm)

    57.61M

Research Analysis: LSI.F

Company Insights: LSI.F

Research Reports: LSI.F